OncoNano Medicine, Inc. — SEC Form D Filing
OncoNano Medicine, Inc. filed an SEC Form D on October 8, 2026, reporting $10.05M raised in Biotechnology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 8, 2026
- Amount reported
- $10.05M
- Round stage
- Series B due to securing a $10M equity round to advance clinical trial pipelines for its lead surgical imaging agent.
- Industry
- Biotechnology
- Website
- https://onconanomed.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Surgeons struggle to precisely differentiate malignant tumor margins from healthy surrounding tissue in real time during surgical resections.
Solution
OncoNano Medicine develops pH-responsive fluorescent nanoprobes that light up acidic tumor environments under near-infrared light for accurate intraoperative visualization and targeted drug delivery.
Why now
Recent breakthroughs in nanoscale pH-sensing materials enable real-time targeted intraoperative imaging that was previously impossible with conventional fluorescent dyes.
Source: SEC EDGAR Form D filing